Issue 113 • December 2021

Digitising the pharma supply chain

Transforming R&D with supercomputers

Covid-19 vaccine pricing around the world

In association with

Drug dealing goes digital 

Without consistent access to vital medications, some patients are forced to turn to other - less legitimate - sources to get hold of prescription drugs

In association with

02/23/2024 21:31:24
  • Home | Drug dealing goes digital 
  • In this issue
  • Contents
  • Syrenis
  • Astrix
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Thermo Fisher Scientific Company Insight
  • Thermo Fisher Scientific
  • Comment
  • Life sciences professionals prioritise quality over cost for PV automation
  • Slow progress for male contraceptive trials
  • Accelerated approval designations in China
  • Mimotopes Company Insight
  • Mimotopes
  • In Depth
  • The dark consequences of supply shortages
  • Digitising the pharma supply chain
  • Covid-19 vaccine pricing varies wildly by country and company 
  • Psychedelics and mental health: the next big thing?
  • Schizophrenia drug landscape: a stagnant field on the cusp of change?
  • Are supercomputers set to transform pharma R&D?
  • BEA Technologies
  • Labcorp
  • In Data
  • North America's AI hiring boom
  • The pharma companies leading the way in artificial intelligence
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
11/18/2021 00:00:00